Zydus Cadila buys out Biochem
December 21st, 2011 - 7:44 pm ICT by IANSAhmedabad, Dec 21 (IANS) Pharmaceutical major Zydus Cadila Wednesday said it has bought out the Mumbai-based Biochem to boost its formulations business.
Biochem has major presence in antibiotics, cardiovascular, anti-diabetic and oncological segments, and Zydus cadila said it has acquired 100 percent stake in it.
“Biochem represents the right fit as they have a significant presence in our core therapy areas and also adds value to our product offerings in the key growth segments,” said Pankaj R. Patel, chairman and managing director of Zydus Cadila.
The acquisition would strengthen Zydus’ operations in the pharma sector’s formulations business, Patel said in a statement.
Biochem owns brands like Ampilox, Biotax, Monotax, Amicin and Zithrocin which together constitute 40 percent of sales. It reported sales of Rs.264.5 crore in the last fiscal.
“The formulations business in India has always been the bulwark of our operations and we have looked at every strategic opportunity to grow and contribute to this market, either by way of novel initiatives, collaborations or acquisitions,” said Patel.
Zydus cadila did not disclose the cost of the acquisition.
– Indo-Asian News Service
mridhula-rv/srj/vt
- Ranbaxy settles issue with US health regulator - Dec 21, 2011
- Havells' China joint venture to make green lighting goods - Dec 26, 2011
- Ahmedabad residents donate 2,000 bottles of blood - Jun 13, 2010
- RBI to issue special coins on century of civil aviation - Dec 27, 2011
- Hospira eyeing Indian partners to make medical devices - Dec 17, 2009
- Zydus Cadila acquires South African firm - Jun 09, 2008
- General Motors showcases two new vehicles - Jan 06, 2012
- Gujarat eyes $1 bn investment for pharma industry - Dec 19, 2010
- HCL Infosystems picks up 60 percent stake in Dubai firm - Jul 08, 2010
- Zydus Cadila acquires Spanish pharma major - May 30, 2008
- Elecon Engineering acquires Britain's Benzlers Radicon Group - Oct 28, 2010
- Kanoria Chemicals to acquire Switzerland-based firm - Apr 20, 2012
- Ranbaxy exit can trigger consolidation of Indian firms - Jun 13, 2008
- Orchid Chemicals completes business transfer to Hospira - Mar 31, 2010
- Orchid Chemicals completes business transfer to Hospira - Mar 31, 2010
Tags: acquisition, acquisitions, ahmedabad, antibiotics, asian news, bulwark, collaborations, crore, growth segments, indo, managing director, news service, oncological, pankaj, percent stake, pharma sector, product offerings, rv, therapy areas, zydus cadila